| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Memory | 27 | 2024 | 1377 | 4.020 |
Why?
|
| Dendritic Cells | 49 | 2023 | 2747 | 3.860 |
Why?
|
| Cell Movement | 78 | 2023 | 5197 | 3.720 |
Why?
|
| Nociceptors | 6 | 2024 | 460 | 3.170 |
Why?
|
| Lymph Nodes | 58 | 2021 | 3466 | 3.040 |
Why?
|
| T-Lymphocytes | 43 | 2022 | 10263 | 1.800 |
Why?
|
| Lymphoid Tissue | 12 | 2008 | 445 | 1.630 |
Why?
|
| L-Selectin | 28 | 2008 | 212 | 1.620 |
Why?
|
| Killer Cells, Natural | 9 | 2021 | 2210 | 1.590 |
Why?
|
| T-Lymphocyte Subsets | 14 | 2022 | 1814 | 1.550 |
Why?
|
| Sensory Receptor Cells | 3 | 2023 | 509 | 1.430 |
Why?
|
| Lymphocytes | 26 | 2017 | 2605 | 1.420 |
Why?
|
| CD8-Positive T-Lymphocytes | 21 | 2022 | 4652 | 1.420 |
Why?
|
| Neutrophils | 29 | 2024 | 3782 | 1.310 |
Why?
|
| Mice | 181 | 2024 | 81863 | 1.240 |
Why?
|
| B-Lymphocytes | 24 | 2020 | 4784 | 1.240 |
Why?
|
| Models, Immunological | 13 | 2014 | 517 | 1.190 |
Why?
|
| Chemotaxis, Leukocyte | 15 | 2011 | 661 | 1.160 |
Why?
|
| Neuroimmunomodulation | 2 | 2023 | 186 | 1.150 |
Why?
|
| Cell Adhesion | 38 | 2023 | 3093 | 1.140 |
Why?
|
| Animals | 233 | 2024 | 168887 | 1.130 |
Why?
|
| Mice, Inbred C57BL | 88 | 2024 | 22337 | 1.100 |
Why?
|
| Lymphocyte Activation | 28 | 2020 | 5502 | 1.080 |
Why?
|
| Duffy Blood-Group System | 4 | 2021 | 61 | 1.020 |
Why?
|
| Venules | 26 | 2024 | 161 | 1.020 |
Why?
|
| Bone Marrow | 13 | 2022 | 2926 | 1.010 |
Why?
|
| Leukocytes | 18 | 2023 | 2033 | 0.990 |
Why?
|
| Thymus Gland | 6 | 2021 | 1260 | 0.980 |
Why?
|
| Cell Communication | 17 | 2019 | 1658 | 0.970 |
Why?
|
| Homeostasis | 9 | 2024 | 3341 | 0.960 |
Why?
|
| Receptors, Lymphocyte Homing | 11 | 2011 | 141 | 0.960 |
Why?
|
| Tretinoin | 6 | 2011 | 524 | 0.930 |
Why?
|
| Adaptive Immunity | 7 | 2024 | 733 | 0.920 |
Why?
|
| Skin | 13 | 2023 | 4498 | 0.910 |
Why?
|
| Blood | 3 | 2021 | 597 | 0.890 |
Why?
|
| Receptors, Chemokine | 12 | 2022 | 652 | 0.880 |
Why?
|
| Chemokine CCL2 | 2 | 2023 | 604 | 0.860 |
Why?
|
| Endothelium, Vascular | 22 | 2021 | 4417 | 0.850 |
Why?
|
| Immunologic Surveillance | 3 | 2016 | 92 | 0.840 |
Why?
|
| Lymphocytic choriomeningitis virus | 5 | 2020 | 176 | 0.830 |
Why?
|
| Blood Platelets | 11 | 2022 | 2465 | 0.820 |
Why?
|
| Bronchitis | 1 | 2023 | 193 | 0.820 |
Why?
|
| Endothelial Cells | 10 | 2024 | 3576 | 0.800 |
Why?
|
| Antigen Presentation | 10 | 2022 | 1251 | 0.780 |
Why?
|
| Vesiculovirus | 4 | 2013 | 52 | 0.760 |
Why?
|
| Hematopoietic Stem Cells | 12 | 2017 | 3407 | 0.740 |
Why?
|
| Macrophages | 15 | 2024 | 5782 | 0.720 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 11 | 2020 | 381 | 0.720 |
Why?
|
| T-Lymphocytes, Regulatory | 12 | 2019 | 3113 | 0.720 |
Why?
|
| Dermatitis, Allergic Contact | 2 | 2021 | 112 | 0.700 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2023 | 326 | 0.690 |
Why?
|
| Chemokines, CC | 10 | 2008 | 285 | 0.680 |
Why?
|
| Antigens | 9 | 2014 | 1441 | 0.680 |
Why?
|
| Cell Adhesion Molecules | 20 | 2017 | 1612 | 0.680 |
Why?
|
| Immunoglobulin A | 3 | 2008 | 992 | 0.670 |
Why?
|
| Integrins | 15 | 2023 | 839 | 0.670 |
Why?
|
| Herpesviridae Infections | 1 | 2021 | 268 | 0.670 |
Why?
|
| Allergy and Immunology | 1 | 2021 | 170 | 0.660 |
Why?
|
| Peripheral Nervous System | 2 | 2023 | 151 | 0.660 |
Why?
|
| P-Selectin | 15 | 2013 | 598 | 0.660 |
Why?
|
| Mice, Knockout | 51 | 2024 | 14466 | 0.650 |
Why?
|
| Adoptive Transfer | 15 | 2022 | 828 | 0.640 |
Why?
|
| Immune System | 5 | 2018 | 800 | 0.620 |
Why?
|
| Receptors, Cell Surface | 6 | 2021 | 2815 | 0.620 |
Why?
|
| Sphingosine | 6 | 2012 | 306 | 0.620 |
Why?
|
| Chemotaxis | 6 | 2008 | 598 | 0.610 |
Why?
|
| Immunity, Mucosal | 4 | 2019 | 499 | 0.610 |
Why?
|
| Bone Marrow Cells | 12 | 2022 | 2413 | 0.600 |
Why?
|
| Inflammation | 24 | 2024 | 10860 | 0.590 |
Why?
|
| Immunomodulation | 2 | 2021 | 548 | 0.580 |
Why?
|
| Chemokines | 9 | 2011 | 962 | 0.560 |
Why?
|
| Immunity, Innate | 12 | 2021 | 3078 | 0.560 |
Why?
|
| Mice, Inbred BALB C | 24 | 2019 | 6217 | 0.560 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 1026 | 0.550 |
Why?
|
| Intra-Abdominal Fat | 1 | 2022 | 624 | 0.540 |
Why?
|
| Chlamydia Infections | 2 | 2020 | 365 | 0.520 |
Why?
|
| Antigens, Surface | 9 | 2016 | 1617 | 0.510 |
Why?
|
| Intestinal Mucosa | 7 | 2014 | 3048 | 0.510 |
Why?
|
| Propylene Glycols | 2 | 2006 | 91 | 0.500 |
Why?
|
| Transendothelial and Transepithelial Migration | 5 | 2024 | 100 | 0.500 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 1008 | 0.500 |
Why?
|
| Th1 Cells | 4 | 2020 | 1040 | 0.490 |
Why?
|
| Arenaviridae Infections | 1 | 2015 | 53 | 0.490 |
Why?
|
| Cell Differentiation | 15 | 2021 | 11648 | 0.480 |
Why?
|
| Microscopy, Video | 7 | 2009 | 241 | 0.480 |
Why?
|
| Monitoring, Immunologic | 1 | 2015 | 99 | 0.480 |
Why?
|
| Chlamydia trachomatis | 2 | 2020 | 239 | 0.470 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 9 | 2010 | 692 | 0.470 |
Why?
|
| Neutrophil Infiltration | 8 | 2024 | 392 | 0.470 |
Why?
|
| Intestines | 8 | 2018 | 1904 | 0.470 |
Why?
|
| Fucosyltransferases | 4 | 2003 | 118 | 0.460 |
Why?
|
| Haptens | 3 | 2010 | 163 | 0.460 |
Why?
|
| Flow Cytometry | 22 | 2022 | 5890 | 0.440 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2006 | 1802 | 0.440 |
Why?
|
| Lysophospholipids | 6 | 2012 | 336 | 0.440 |
Why?
|
| Endothelium, Lymphatic | 4 | 2007 | 63 | 0.440 |
Why?
|
| Antigen-Presenting Cells | 6 | 2022 | 960 | 0.430 |
Why?
|
| Lymph | 3 | 2009 | 78 | 0.420 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 7 | 2013 | 265 | 0.420 |
Why?
|
| Yolk Sac | 1 | 2013 | 79 | 0.420 |
Why?
|
| Bacterial Vaccines | 1 | 2015 | 400 | 0.420 |
Why?
|
| Signal Transduction | 24 | 2024 | 23611 | 0.420 |
Why?
|
| Viruses | 3 | 2011 | 371 | 0.410 |
Why?
|
| Dermatitis, Contact | 4 | 2013 | 134 | 0.410 |
Why?
|
| Rhabdoviridae Infections | 2 | 2010 | 9 | 0.400 |
Why?
|
| Interleukin-23 | 1 | 2014 | 202 | 0.400 |
Why?
|
| Vesicular Stomatitis | 1 | 2012 | 18 | 0.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 11 | 2021 | 4410 | 0.390 |
Why?
|
| Mice, Transgenic | 27 | 2020 | 9539 | 0.390 |
Why?
|
| Interferon Type I | 4 | 2021 | 568 | 0.380 |
Why?
|
| Immune Tolerance | 4 | 2017 | 2324 | 0.380 |
Why?
|
| E-Selectin | 11 | 2012 | 575 | 0.380 |
Why?
|
| Fetal Stem Cells | 1 | 2011 | 11 | 0.380 |
Why?
|
| Receptors, CXCR | 2 | 2013 | 52 | 0.380 |
Why?
|
| Peyer's Patches | 5 | 2005 | 120 | 0.370 |
Why?
|
| Uterus | 1 | 2015 | 660 | 0.370 |
Why?
|
| Integrin alpha4 | 4 | 2008 | 89 | 0.350 |
Why?
|
| Thrombopoiesis | 2 | 2012 | 160 | 0.340 |
Why?
|
| Receptors, Immunologic | 3 | 2013 | 1418 | 0.340 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 592 | 0.340 |
Why?
|
| Adult Stem Cells | 2 | 2011 | 221 | 0.340 |
Why?
|
| Sulfotransferases | 3 | 2005 | 151 | 0.330 |
Why?
|
| Vaccination | 3 | 2019 | 3434 | 0.330 |
Why?
|
| Microvilli | 4 | 2001 | 234 | 0.330 |
Why?
|
| Lymphocyte Subsets | 1 | 2010 | 313 | 0.330 |
Why?
|
| Nanoparticles | 6 | 2018 | 1966 | 0.330 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2006 | 551 | 0.320 |
Why?
|
| Staining and Labeling | 5 | 2017 | 1073 | 0.310 |
Why?
|
| Platelet Activation | 6 | 2017 | 643 | 0.310 |
Why?
|
| Selectins | 6 | 2014 | 101 | 0.310 |
Why?
|
| Microvessels | 1 | 2013 | 586 | 0.310 |
Why?
|
| Interferon-gamma | 6 | 2020 | 3159 | 0.310 |
Why?
|
| Cytokines | 14 | 2021 | 7436 | 0.310 |
Why?
|
| Monocytes | 6 | 2022 | 2599 | 0.300 |
Why?
|
| Lymphatic System | 2 | 2007 | 250 | 0.300 |
Why?
|
| Membrane Glycoproteins | 10 | 2013 | 3702 | 0.300 |
Why?
|
| Vitamin A | 2 | 2008 | 611 | 0.300 |
Why?
|
| Myeloid Cells | 4 | 2023 | 838 | 0.300 |
Why?
|
| Antibody-Producing Cells | 1 | 2008 | 140 | 0.290 |
Why?
|
| Gastrointestinal Tract | 3 | 2009 | 834 | 0.290 |
Why?
|
| Intercellular Adhesion Molecule-1 | 9 | 2024 | 1131 | 0.290 |
Why?
|
| Leukocyte Rolling | 6 | 2013 | 69 | 0.290 |
Why?
|
| Megakaryocytes | 2 | 2012 | 557 | 0.290 |
Why?
|
| Leukotriene B4 | 4 | 2003 | 281 | 0.280 |
Why?
|
| Gene Expression Regulation | 10 | 2024 | 11919 | 0.280 |
Why?
|
| Cells, Cultured | 26 | 2015 | 18979 | 0.280 |
Why?
|
| Cell Lineage | 5 | 2013 | 2573 | 0.280 |
Why?
|
| Stem Cells | 5 | 2018 | 3538 | 0.280 |
Why?
|
| Chemokines, CXC | 7 | 2012 | 420 | 0.280 |
Why?
|
| Clonal Deletion | 1 | 2006 | 75 | 0.270 |
Why?
|
| Toll-Like Receptors | 5 | 2020 | 582 | 0.270 |
Why?
|
| Spleen | 9 | 2016 | 2294 | 0.270 |
Why?
|
| Psoriasis | 2 | 2014 | 925 | 0.260 |
Why?
|
| Intestine, Small | 4 | 2014 | 1217 | 0.260 |
Why?
|
| Immunosuppressive Agents | 6 | 2022 | 4215 | 0.260 |
Why?
|
| Microscopy, Fluorescence | 6 | 2014 | 2629 | 0.260 |
Why?
|
| Adipose Tissue | 4 | 2022 | 3314 | 0.260 |
Why?
|
| Dinitrofluorobenzene | 2 | 2021 | 14 | 0.260 |
Why?
|
| Quantum Dots | 1 | 2007 | 166 | 0.260 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2017 | 1352 | 0.260 |
Why?
|
| Humans | 114 | 2024 | 766432 | 0.260 |
Why?
|
| Receptors, Leukotriene B4 | 2 | 2003 | 93 | 0.250 |
Why?
|
| Capillaries | 3 | 2006 | 754 | 0.250 |
Why?
|
| Stromal Cells | 2 | 2012 | 1335 | 0.250 |
Why?
|
| Central Nervous System | 2 | 2010 | 1345 | 0.250 |
Why?
|
| Antigens, CD | 7 | 2024 | 4031 | 0.250 |
Why?
|
| Blood Vessels | 4 | 2013 | 1111 | 0.250 |
Why?
|
| Chemokine CX3CL1 | 2 | 2023 | 61 | 0.240 |
Why?
|
| Erythroblasts | 2 | 2017 | 142 | 0.240 |
Why?
|
| Vesicular stomatitis Indiana virus | 3 | 2012 | 93 | 0.230 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2024 | 255 | 0.230 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 2010 | 168 | 0.230 |
Why?
|
| Self Tolerance | 2 | 2021 | 119 | 0.230 |
Why?
|
| Diphosphonates | 2 | 2023 | 625 | 0.230 |
Why?
|
| Autoantigens | 3 | 2021 | 886 | 0.230 |
Why?
|
| Liver | 10 | 2021 | 7570 | 0.230 |
Why?
|
| Receptors, CCR | 4 | 2009 | 37 | 0.230 |
Why?
|
| Adjuvants, Immunologic | 4 | 2015 | 995 | 0.220 |
Why?
|
| Fluorescent Dyes | 5 | 2015 | 1927 | 0.220 |
Why?
|
| Digestive System | 1 | 2004 | 244 | 0.220 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2022 | 1851 | 0.220 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 2014 | 705 | 0.220 |
Why?
|
| Membrane Proteins | 10 | 2016 | 7866 | 0.210 |
Why?
|
| Mucous Membrane | 2 | 2018 | 658 | 0.210 |
Why?
|
| Fungal Proteins | 1 | 2007 | 900 | 0.210 |
Why?
|
| Bleomycin | 1 | 2024 | 491 | 0.210 |
Why?
|
| Luminescent Proteins | 6 | 2013 | 839 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2012 | 2570 | 0.210 |
Why?
|
| Peptides | 5 | 2024 | 4344 | 0.210 |
Why?
|
| Immunity | 3 | 2024 | 1002 | 0.210 |
Why?
|
| Disease Models, Animal | 15 | 2024 | 18322 | 0.210 |
Why?
|
| Vitamins | 2 | 2008 | 1630 | 0.210 |
Why?
|
| Lymphocytic Choriomeningitis | 3 | 2020 | 140 | 0.210 |
Why?
|
| Interphase | 1 | 2003 | 226 | 0.210 |
Why?
|
| Interleukin-10 | 3 | 2018 | 1182 | 0.200 |
Why?
|
| Microscopy | 3 | 2004 | 901 | 0.200 |
Why?
|
| Chemokine CXCL1 | 2 | 2021 | 102 | 0.200 |
Why?
|
| Osteopontin | 1 | 2024 | 306 | 0.200 |
Why?
|
| Receptors, IgG | 2 | 2021 | 562 | 0.190 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 367 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 9 | 2023 | 9243 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 5 | 2017 | 2062 | 0.190 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 4 | 2011 | 144 | 0.190 |
Why?
|
| Receptors, CXCR3 | 2 | 2012 | 241 | 0.190 |
Why?
|
| Muromegalovirus | 1 | 2021 | 31 | 0.180 |
Why?
|
| Biological Transport | 3 | 2021 | 2083 | 0.180 |
Why?
|
| Antibody Formation | 6 | 2014 | 1392 | 0.180 |
Why?
|
| Mice, SCID | 4 | 2021 | 2626 | 0.180 |
Why?
|
| Retinal Neovascularization | 1 | 2024 | 287 | 0.180 |
Why?
|
| Nasal Mucosa | 1 | 2024 | 416 | 0.180 |
Why?
|
| Virus Diseases | 2 | 2021 | 720 | 0.180 |
Why?
|
| Chemokine CXCL2 | 2 | 2018 | 105 | 0.180 |
Why?
|
| Tumor Escape | 1 | 2023 | 372 | 0.180 |
Why?
|
| Benzenesulfonates | 1 | 2021 | 170 | 0.180 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 504 | 0.170 |
Why?
|
| Bacteria, Anaerobic | 2 | 2017 | 71 | 0.170 |
Why?
|
| Interleukin-17 | 2 | 2018 | 923 | 0.170 |
Why?
|
| Natural Killer T-Cells | 2 | 2014 | 319 | 0.170 |
Why?
|
| Receptors, Lysosphingolipid | 2 | 2012 | 121 | 0.160 |
Why?
|
| Ligands | 11 | 2014 | 3276 | 0.160 |
Why?
|
| Lung Injury | 1 | 2024 | 432 | 0.160 |
Why?
|
| Chemokine CCL22 | 1 | 2019 | 27 | 0.160 |
Why?
|
| Genitalia | 1 | 2020 | 114 | 0.160 |
Why?
|
| Vaccinia virus | 2 | 2017 | 328 | 0.160 |
Why?
|
| Ghrelin | 1 | 2021 | 254 | 0.160 |
Why?
|
| Urinary Bladder | 2 | 2021 | 1155 | 0.160 |
Why?
|
| Appetite | 1 | 2021 | 247 | 0.160 |
Why?
|
| Somatostatin | 1 | 2021 | 459 | 0.160 |
Why?
|
| Endothelium | 5 | 2009 | 768 | 0.160 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 2018 | 975 | 0.160 |
Why?
|
| Prodrugs | 1 | 2021 | 274 | 0.160 |
Why?
|
| Pain | 2 | 2024 | 5097 | 0.150 |
Why?
|
| Mucoproteins | 4 | 2008 | 49 | 0.150 |
Why?
|
| Germinal Center | 3 | 2012 | 379 | 0.150 |
Why?
|
| Cell Separation | 2 | 2016 | 1718 | 0.150 |
Why?
|
| Receptors, Interleukin-8B | 2 | 2021 | 58 | 0.150 |
Why?
|
| RNA, Small Interfering | 4 | 2015 | 3424 | 0.150 |
Why?
|
| Mast Cells | 2 | 2023 | 1405 | 0.150 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2021 | 820 | 0.150 |
Why?
|
| Glycosphingolipids | 1 | 2018 | 72 | 0.150 |
Why?
|
| Immunotherapy | 5 | 2022 | 4749 | 0.150 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2018 | 50 | 0.150 |
Why?
|
| Sympathetic Nervous System | 1 | 2020 | 520 | 0.150 |
Why?
|
| Isoenzymes | 2 | 2007 | 1688 | 0.150 |
Why?
|
| Oligosaccharides | 3 | 2018 | 406 | 0.150 |
Why?
|
| Macrophages, Peritoneal | 4 | 2013 | 243 | 0.140 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 2008 | 360 | 0.140 |
Why?
|
| Integrin alpha4beta1 | 3 | 2008 | 119 | 0.140 |
Why?
|
| Actins | 3 | 2023 | 2060 | 0.140 |
Why?
|
| Tacrolimus | 2 | 2018 | 753 | 0.140 |
Why?
|
| DNA-Binding Proteins | 8 | 2021 | 9611 | 0.140 |
Why?
|
| Female | 50 | 2024 | 396354 | 0.140 |
Why?
|
| Chemokine CXCL12 | 6 | 2009 | 457 | 0.140 |
Why?
|
| Vaccinia | 1 | 2017 | 71 | 0.140 |
Why?
|
| Lymphocyte Count | 4 | 2011 | 794 | 0.140 |
Why?
|
| Protein Kinase C | 2 | 2001 | 1206 | 0.140 |
Why?
|
| Polymers | 2 | 2014 | 1624 | 0.140 |
Why?
|
| Lymphedema | 1 | 2023 | 526 | 0.140 |
Why?
|
| Microcirculation | 7 | 2010 | 1282 | 0.140 |
Why?
|
| Sialoglycoproteins | 1 | 1998 | 316 | 0.140 |
Why?
|
| Models, Animal | 2 | 2021 | 2119 | 0.140 |
Why?
|
| Microfluidics | 1 | 2022 | 650 | 0.130 |
Why?
|
| Antigens, Neoplasm | 2 | 2022 | 1998 | 0.130 |
Why?
|
| Immunity, Humoral | 3 | 2020 | 608 | 0.130 |
Why?
|
| Blood-Brain Barrier | 2 | 2021 | 1028 | 0.130 |
Why?
|
| Chemokine CCL21 | 4 | 2007 | 49 | 0.130 |
Why?
|
| Hemostasis | 2 | 2017 | 467 | 0.130 |
Why?
|
| Cell Line | 9 | 2014 | 15563 | 0.130 |
Why?
|
| Neurons | 1 | 2015 | 9515 | 0.130 |
Why?
|
| Ovalbumin | 3 | 2014 | 676 | 0.130 |
Why?
|
| Drug Delivery Systems | 3 | 2016 | 2210 | 0.130 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2014 | 197 | 0.130 |
Why?
|
| Chemokine CXCL9 | 2 | 2012 | 137 | 0.130 |
Why?
|
| Male | 49 | 2024 | 363975 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 761 | 0.130 |
Why?
|
| Reflex | 1 | 2017 | 375 | 0.130 |
Why?
|
| Langerhans Cells | 2 | 2014 | 169 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2018 | 696 | 0.120 |
Why?
|
| Peptidoglycan | 1 | 2017 | 246 | 0.120 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2022 | 1362 | 0.120 |
Why?
|
| Hemodynamics | 7 | 2002 | 4187 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2009 | 8925 | 0.120 |
Why?
|
| Keratitis, Herpetic | 1 | 2015 | 76 | 0.120 |
Why?
|
| Microglia | 1 | 2024 | 1370 | 0.120 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 93 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2021 | 1574 | 0.120 |
Why?
|
| Neuraminidase | 2 | 2011 | 192 | 0.120 |
Why?
|
| Adrenal Glands | 1 | 2017 | 556 | 0.120 |
Why?
|
| Lipopolysaccharides | 4 | 2017 | 2215 | 0.120 |
Why?
|
| Kidney Cortex | 1 | 2014 | 167 | 0.120 |
Why?
|
| Vitamin D | 1 | 2008 | 3270 | 0.120 |
Why?
|
| RGS Proteins | 1 | 2014 | 76 | 0.120 |
Why?
|
| Fusion Proteins, bcr-abl | 3 | 2014 | 429 | 0.120 |
Why?
|
| Vaccines, Inactivated | 1 | 2015 | 186 | 0.120 |
Why?
|
| Peritonitis | 4 | 2015 | 368 | 0.120 |
Why?
|
| Fetus | 2 | 2012 | 1878 | 0.120 |
Why?
|
| Kinetics | 4 | 2008 | 6285 | 0.120 |
Why?
|
| Chemotactic Factors | 2 | 2008 | 197 | 0.120 |
Why?
|
| Cell Division | 6 | 2007 | 4474 | 0.110 |
Why?
|
| Interleukin-1 | 3 | 1994 | 1251 | 0.110 |
Why?
|
| Wound Healing | 2 | 2024 | 2798 | 0.110 |
Why?
|
| Mesenteric Veins | 1 | 1994 | 87 | 0.110 |
Why?
|
| Organ Specificity | 4 | 2017 | 1966 | 0.110 |
Why?
|
| Pituitary-Adrenal System | 1 | 2017 | 553 | 0.110 |
Why?
|
| Aminoquinolines | 1 | 2014 | 105 | 0.110 |
Why?
|
| Drug Carriers | 1 | 2018 | 702 | 0.110 |
Why?
|
| Bacteroides fragilis | 1 | 2015 | 250 | 0.110 |
Why?
|
| Interleukin-2 | 4 | 2014 | 1894 | 0.110 |
Why?
|
| Diagnostic Imaging | 2 | 2006 | 3530 | 0.110 |
Why?
|
| Aging | 2 | 2024 | 8725 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 13639 | 0.110 |
Why?
|
| Axotomy | 1 | 2013 | 71 | 0.110 |
Why?
|
| Immunologic Techniques | 3 | 2011 | 212 | 0.110 |
Why?
|
| Thermogenesis | 1 | 2018 | 495 | 0.110 |
Why?
|
| Neoplasms | 8 | 2022 | 22343 | 0.110 |
Why?
|
| Action Potentials | 1 | 2020 | 1829 | 0.110 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2017 | 702 | 0.110 |
Why?
|
| Immunoglobulins | 3 | 2008 | 853 | 0.110 |
Why?
|
| Dextrans | 1 | 2015 | 573 | 0.100 |
Why?
|
| Metalloendopeptidases | 3 | 2004 | 386 | 0.100 |
Why?
|
| Veins | 1 | 2017 | 770 | 0.100 |
Why?
|
| Neutropenia | 2 | 2017 | 894 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2021 | 582 | 0.100 |
Why?
|
| Kupffer Cells | 2 | 2011 | 143 | 0.100 |
Why?
|
| Lung | 4 | 2024 | 10064 | 0.100 |
Why?
|
| Lymphotoxin alpha1, beta2 Heterotrimer | 1 | 2012 | 4 | 0.100 |
Why?
|
| Interleukins | 2 | 2014 | 794 | 0.100 |
Why?
|
| Antigens, Viral | 3 | 2001 | 995 | 0.100 |
Why?
|
| Receptors, CCR7 | 5 | 2007 | 105 | 0.100 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 243 | 0.100 |
Why?
|
| Lymphocyte Cooperation | 1 | 2012 | 112 | 0.100 |
Why?
|
| Viral Vaccines | 1 | 2017 | 596 | 0.100 |
Why?
|
| Refrigeration | 1 | 2011 | 27 | 0.100 |
Why?
|
| Cancer Vaccines | 1 | 2019 | 1042 | 0.100 |
Why?
|
| Prostheses and Implants | 2 | 2016 | 1274 | 0.100 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1991 | 53 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 2014 | 592 | 0.100 |
Why?
|
| Trigeminal Nerve | 1 | 2013 | 248 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 506 | 0.100 |
Why?
|
| Angiotensin II | 1 | 2014 | 844 | 0.100 |
Why?
|
| Metalloproteases | 1 | 2011 | 60 | 0.100 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 1689 | 0.090 |
Why?
|
| Skull | 3 | 2002 | 819 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 2 | 2021 | 512 | 0.090 |
Why?
|
| Vaccines, Synthetic | 1 | 2014 | 620 | 0.090 |
Why?
|
| Models, Biological | 9 | 2022 | 9458 | 0.090 |
Why?
|
| Calcium | 3 | 2023 | 5781 | 0.090 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2015 | 543 | 0.090 |
Why?
|
| Antibodies | 3 | 2016 | 2421 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2003 | 2249 | 0.090 |
Why?
|
| Vesicular stomatitis New Jersey virus | 1 | 2010 | 1 | 0.090 |
Why?
|
| Interleukin-12 | 1 | 2013 | 581 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2014 | 966 | 0.090 |
Why?
|
| Multiple Sclerosis | 2 | 2021 | 3229 | 0.090 |
Why?
|
| Endosomes | 1 | 2013 | 521 | 0.090 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2015 | 426 | 0.090 |
Why?
|
| Transfection | 6 | 2007 | 5750 | 0.090 |
Why?
|
| Interleukin-15 | 2 | 2001 | 186 | 0.090 |
Why?
|
| Distamycins | 1 | 2010 | 10 | 0.090 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2017 | 220 | 0.090 |
Why?
|
| Oxazolone | 3 | 2006 | 61 | 0.090 |
Why?
|
| Phagocytosis | 5 | 2016 | 1527 | 0.090 |
Why?
|
| Protein Conformation | 4 | 2008 | 3946 | 0.090 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 347 | 0.090 |
Why?
|
| Dermatitis, Atopic | 1 | 2018 | 734 | 0.090 |
Why?
|
| Graft Survival | 2 | 2018 | 3904 | 0.090 |
Why?
|
| Mice, Mutant Strains | 6 | 2010 | 1750 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 701 | 0.090 |
Why?
|
| Protein Binding | 7 | 2012 | 9315 | 0.090 |
Why?
|
| Cell Tracking | 1 | 2011 | 139 | 0.090 |
Why?
|
| Crohn Disease | 1 | 2003 | 2285 | 0.090 |
Why?
|
| Ultraviolet Rays | 1 | 2015 | 1101 | 0.090 |
Why?
|
| Simian immunodeficiency virus | 1 | 2015 | 812 | 0.090 |
Why?
|
| Microscopy, Confocal | 4 | 2017 | 1967 | 0.090 |
Why?
|
| HMGA1a Protein | 1 | 2010 | 63 | 0.080 |
Why?
|
| Trigeminal Ganglion | 1 | 2011 | 186 | 0.080 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2010 | 113 | 0.080 |
Why?
|
| Influenza A virus | 2 | 2024 | 455 | 0.080 |
Why?
|
| Conjunctiva | 1 | 2013 | 477 | 0.080 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 928 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 3 | 2006 | 2730 | 0.080 |
Why?
|
| Herpesvirus 1, Human | 2 | 2015 | 743 | 0.080 |
Why?
|
| Heparitin Sulfate | 1 | 2010 | 223 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2007 | 3736 | 0.080 |
Why?
|
| Intercellular Junctions | 2 | 2021 | 198 | 0.080 |
Why?
|
| Receptors, Interleukin-2 | 3 | 2006 | 564 | 0.080 |
Why?
|
| Epithelial Cells | 4 | 2024 | 3689 | 0.080 |
Why?
|
| Sirolimus | 2 | 2014 | 1541 | 0.080 |
Why?
|
| Immunophenotyping | 3 | 2022 | 1866 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 5 | 2003 | 6105 | 0.080 |
Why?
|
| Autoimmunity | 2 | 2010 | 1356 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2013 | 910 | 0.080 |
Why?
|
| Interleukin-6 | 3 | 2013 | 3226 | 0.080 |
Why?
|
| Injections | 2 | 2010 | 839 | 0.080 |
Why?
|
| HIV | 2 | 2015 | 1588 | 0.080 |
Why?
|
| Embryonic Development | 2 | 2011 | 719 | 0.080 |
Why?
|
| Thrombocytopenia | 2 | 2017 | 1172 | 0.080 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2014 | 685 | 0.080 |
Why?
|
| Allosteric Regulation | 2 | 2007 | 425 | 0.080 |
Why?
|
| Rabbits | 5 | 1997 | 4752 | 0.080 |
Why?
|
| Paralysis | 1 | 2010 | 250 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 3943 | 0.080 |
Why?
|
| Blood Cells | 3 | 2002 | 308 | 0.080 |
Why?
|
| Endotoxemia | 1 | 2010 | 198 | 0.080 |
Why?
|
| Coculture Techniques | 3 | 2013 | 1336 | 0.080 |
Why?
|
| Time Factors | 11 | 2013 | 40116 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2024 | 12147 | 0.080 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 1105 | 0.080 |
Why?
|
| Vibrio cholerae | 1 | 2014 | 793 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 377 | 0.080 |
Why?
|
| Thrombosis | 3 | 2017 | 2950 | 0.080 |
Why?
|
| Glycosylation | 4 | 2020 | 1100 | 0.080 |
Why?
|
| Major Histocompatibility Complex | 2 | 2008 | 880 | 0.080 |
Why?
|
| Hepatic Stellate Cells | 1 | 2009 | 117 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 2001 | 825 | 0.070 |
Why?
|
| Gastric Mucosa | 1 | 2011 | 602 | 0.070 |
Why?
|
| Virus Latency | 1 | 2011 | 359 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 1043 | 0.070 |
Why?
|
| Down-Regulation | 3 | 2006 | 2930 | 0.070 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2007 | 51 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 3757 | 0.070 |
Why?
|
| Blood Physiological Phenomena | 1 | 2007 | 53 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2017 | 2060 | 0.070 |
Why?
|
| Eye Diseases | 1 | 2013 | 660 | 0.070 |
Why?
|
| Dinucleoside Phosphates | 1 | 2007 | 71 | 0.070 |
Why?
|
| Macrophage-1 Antigen | 3 | 2003 | 286 | 0.070 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2007 | 63 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2014 | 1805 | 0.070 |
Why?
|
| Cell Proliferation | 5 | 2021 | 10438 | 0.070 |
Why?
|
| RNA Interference | 2 | 2014 | 2825 | 0.070 |
Why?
|
| Heart Transplantation | 2 | 2018 | 3299 | 0.070 |
Why?
|
| Herpes Simplex | 1 | 2011 | 470 | 0.070 |
Why?
|
| Cofilin 1 | 1 | 2007 | 14 | 0.070 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2007 | 98 | 0.070 |
Why?
|
| Thoracic Duct | 1 | 2007 | 71 | 0.070 |
Why?
|
| Polysaccharides | 2 | 2020 | 1020 | 0.070 |
Why?
|
| Platelet Transfusion | 3 | 2017 | 301 | 0.070 |
Why?
|
| Nitrophenols | 1 | 2007 | 169 | 0.070 |
Why?
|
| Shear Strength | 1 | 2007 | 160 | 0.070 |
Why?
|
| Lymphatic Vessels | 2 | 2016 | 356 | 0.070 |
Why?
|
| Hagfishes | 1 | 2006 | 12 | 0.070 |
Why?
|
| Mesentery | 2 | 2021 | 200 | 0.070 |
Why?
|
| Apoptosis | 6 | 2011 | 9507 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2016 | 1594 | 0.070 |
Why?
|
| Protein Subunits | 2 | 2007 | 940 | 0.070 |
Why?
|
| Histocompatibility Antigens | 1 | 2008 | 479 | 0.070 |
Why?
|
| Immunization | 3 | 2022 | 1218 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2006 | 34 | 0.070 |
Why?
|
| Peripheral Nerves | 1 | 2010 | 490 | 0.070 |
Why?
|
| Caspases | 2 | 2007 | 881 | 0.070 |
Why?
|
| Vitamin A Deficiency | 1 | 2006 | 88 | 0.070 |
Why?
|
| Neoplasm Transplantation | 2 | 2016 | 2010 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2007 | 723 | 0.070 |
Why?
|
| Hepatocytes | 2 | 2011 | 1247 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2013 | 1366 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 1324 | 0.060 |
Why?
|
| Interleukin-5 | 1 | 2006 | 268 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 398 | 0.060 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2007 | 572 | 0.060 |
Why?
|
| Leukocyte Count | 4 | 2015 | 1606 | 0.060 |
Why?
|
| Mice, Congenic | 1 | 2005 | 98 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 1351 | 0.060 |
Why?
|
| Mammals | 2 | 2023 | 1134 | 0.060 |
Why?
|
| Hepatitis B | 1 | 2011 | 709 | 0.060 |
Why?
|
| Collagen | 3 | 2009 | 2634 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 2014 | 5129 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 1675 | 0.060 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2008 | 577 | 0.060 |
Why?
|
| Receptors, Nicotinic | 1 | 2008 | 494 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2008 | 1159 | 0.060 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2006 | 306 | 0.060 |
Why?
|
| Arterioles | 2 | 2014 | 251 | 0.060 |
Why?
|
| Phenotype | 2 | 2022 | 16721 | 0.060 |
Why?
|
| Transcellular Cell Migration | 1 | 2024 | 3 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 1396 | 0.060 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 94 | 0.060 |
Why?
|
| Transplantation, Homologous | 4 | 2019 | 4860 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4566 | 0.060 |
Why?
|
| Cell Membrane | 3 | 2011 | 3640 | 0.060 |
Why?
|
| Integrin alpha1 | 1 | 2004 | 13 | 0.060 |
Why?
|
| Nanotechnology | 1 | 2010 | 702 | 0.060 |
Why?
|
| Complement C1q | 1 | 2004 | 93 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2017 | 2470 | 0.060 |
Why?
|
| Stress, Mechanical | 3 | 2010 | 1672 | 0.060 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2008 | 565 | 0.060 |
Why?
|
| Antigens, Differentiation | 2 | 2011 | 921 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 1 | 2007 | 465 | 0.060 |
Why?
|
| Cold Temperature | 2 | 2003 | 795 | 0.060 |
Why?
|
| Protein Engineering | 1 | 2007 | 554 | 0.050 |
Why?
|
| Melanoma, Experimental | 2 | 2018 | 556 | 0.050 |
Why?
|
| Endocytosis | 2 | 2021 | 952 | 0.050 |
Why?
|
| Receptor, trkB | 1 | 2024 | 123 | 0.050 |
Why?
|
| Arthritis, Experimental | 1 | 2006 | 293 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2006 | 546 | 0.050 |
Why?
|
| Omentum | 1 | 2024 | 168 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2007 | 1749 | 0.050 |
Why?
|
| Immunohistochemistry | 5 | 2014 | 11059 | 0.050 |
Why?
|
| Dipeptides | 2 | 2004 | 386 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 1117 | 0.050 |
Why?
|
| Ear | 2 | 2002 | 172 | 0.050 |
Why?
|
| Chymotrypsin | 2 | 1993 | 136 | 0.050 |
Why?
|
| Fibrosis | 2 | 2023 | 2076 | 0.050 |
Why?
|
| Eosinophils | 2 | 2000 | 952 | 0.050 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 2534 | 0.050 |
Why?
|
| Air | 1 | 2003 | 182 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 2 | 2024 | 2629 | 0.050 |
Why?
|
| Hydroxamic Acids | 2 | 2004 | 483 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 1331 | 0.050 |
Why?
|
| Melanoma | 2 | 2016 | 5699 | 0.050 |
Why?
|
| Lasers | 2 | 2007 | 951 | 0.050 |
Why?
|
| Muscle, Skeletal | 4 | 2009 | 4966 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2009 | 1997 | 0.050 |
Why?
|
| Trifluoperazine | 1 | 2001 | 40 | 0.050 |
Why?
|
| Capillary Leak Syndrome | 1 | 2002 | 34 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 2010 | 0.050 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2007 | 747 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 3107 | 0.050 |
Why?
|
| Freund's Adjuvant | 1 | 2001 | 144 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2007 | 1129 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2003 | 684 | 0.050 |
Why?
|
| Splanchnic Circulation | 2 | 1992 | 122 | 0.050 |
Why?
|
| Computational Biology | 2 | 2014 | 3564 | 0.050 |
Why?
|
| Lipoproteins, LDL | 2 | 1995 | 642 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2006 | 1227 | 0.050 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 9521 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2007 | 3610 | 0.050 |
Why?
|
| Thrombospondins | 1 | 2002 | 197 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2010 | 2205 | 0.050 |
Why?
|
| Thrombomodulin | 1 | 2001 | 107 | 0.050 |
Why?
|
| Chemokine CCL19 | 3 | 2007 | 37 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2023 | 484 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2009 | 1161 | 0.040 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2003 | 316 | 0.040 |
Why?
|
| Calmodulin | 1 | 2001 | 240 | 0.040 |
Why?
|
| Blood Circulation | 1 | 2001 | 248 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 1121 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2012 | 3211 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2002 | 877 | 0.040 |
Why?
|
| Heparin | 1 | 2007 | 1634 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2024 | 606 | 0.040 |
Why?
|
| Pregnancy | 2 | 2013 | 30235 | 0.040 |
Why?
|
| Anti-Retroviral Agents | 1 | 2010 | 1786 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5453 | 0.040 |
Why?
|
| Immunity, Cellular | 2 | 2014 | 1560 | 0.040 |
Why?
|
| Insulin | 1 | 2014 | 6608 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2008 | 1885 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2002 | 789 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2003 | 536 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2021 | 300 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2004 | 631 | 0.040 |
Why?
|
| Fluorescence | 2 | 2017 | 751 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2024 | 872 | 0.040 |
Why?
|
| Mesoderm | 1 | 2003 | 679 | 0.040 |
Why?
|
| Cadherins | 1 | 2024 | 901 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2005 | 1078 | 0.040 |
Why?
|
| DNA Primers | 1 | 2003 | 2824 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 2900 | 0.040 |
Why?
|
| Fas Ligand Protein | 1 | 1999 | 214 | 0.040 |
Why?
|
| Fever | 1 | 2006 | 1607 | 0.040 |
Why?
|
| Cell Line, Tumor | 5 | 2019 | 17082 | 0.040 |
Why?
|
| Bacterial Proteins | 2 | 2014 | 3833 | 0.040 |
Why?
|
| Receptors, CCR4 | 1 | 2019 | 77 | 0.040 |
Why?
|
| Disulfides | 1 | 2001 | 462 | 0.040 |
Why?
|
| Reactive Oxygen Species | 3 | 2021 | 2143 | 0.040 |
Why?
|
| Rhodamine 123 | 1 | 1998 | 37 | 0.040 |
Why?
|
| Gene Expression | 3 | 2013 | 7583 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2022 | 1647 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5789 | 0.040 |
Why?
|
| Arteries | 2 | 2013 | 1121 | 0.040 |
Why?
|
| Binding Sites | 1 | 2007 | 6010 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 2021 | 349 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 54826 | 0.040 |
Why?
|
| Salmonella enterica | 1 | 2018 | 75 | 0.040 |
Why?
|
| Bacteremia | 1 | 2005 | 987 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2003 | 833 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2018 | 9 | 0.040 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2018 | 12 | 0.040 |
Why?
|
| Mice, Inbred AKR | 1 | 1998 | 103 | 0.040 |
Why?
|
| DNA | 1 | 2012 | 7207 | 0.040 |
Why?
|
| Transcytosis | 1 | 2018 | 48 | 0.040 |
Why?
|
| Leukemia | 1 | 2006 | 1521 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2004 | 17605 | 0.040 |
Why?
|
| G(M1) Ganglioside | 1 | 2018 | 87 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 323 | 0.040 |
Why?
|
| Rhodamines | 1 | 1998 | 178 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 1600 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2001 | 637 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2009 | 2799 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 2009 | 2551 | 0.040 |
Why?
|
| Immunoglobulin G | 4 | 2013 | 4559 | 0.040 |
Why?
|
| Hypersensitivity, Delayed | 2 | 2014 | 491 | 0.040 |
Why?
|
| HIV-1 | 1 | 2015 | 6948 | 0.040 |
Why?
|
| Abdominal Muscles | 1 | 2018 | 172 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2014 | 1646 | 0.040 |
Why?
|
| Solutions | 1 | 2018 | 405 | 0.040 |
Why?
|
| Survival Rate | 2 | 2010 | 12825 | 0.040 |
Why?
|
| Receptors, Thromboxane | 1 | 1997 | 30 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2007 | 5385 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 2 | 2017 | 1466 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2019 | 4270 | 0.040 |
Why?
|
| Protein Folding | 1 | 2001 | 868 | 0.030 |
Why?
|
| Inflammation Mediators | 2 | 2016 | 1889 | 0.030 |
Why?
|
| Ceramides | 1 | 2018 | 202 | 0.030 |
Why?
|
| ADAM Proteins | 2 | 2011 | 243 | 0.030 |
Why?
|
| Cornea | 2 | 2015 | 1315 | 0.030 |
Why?
|
| Platelet Adhesiveness | 1 | 2017 | 154 | 0.030 |
Why?
|
| Cell Survival | 3 | 2018 | 5741 | 0.030 |
Why?
|
| Click Chemistry | 1 | 2017 | 100 | 0.030 |
Why?
|
| HIV Infections | 3 | 2015 | 17534 | 0.030 |
Why?
|
| Base Sequence | 2 | 2007 | 12412 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2017 | 26388 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2023 | 81588 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2008 | 4888 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2011 | 2432 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 5860 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2011 | 12788 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 3 | 2007 | 221 | 0.030 |
Why?
|
| Epitopes | 2 | 2005 | 2526 | 0.030 |
Why?
|
| Gestational Age | 2 | 2017 | 3617 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2018 | 354 | 0.030 |
Why?
|
| Proteins | 2 | 2014 | 6002 | 0.030 |
Why?
|
| Receptors, NK Cell Lectin-Like | 1 | 2015 | 30 | 0.030 |
Why?
|
| Amino Acid Chloromethyl Ketones | 2 | 2007 | 68 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 2018 | 3053 | 0.030 |
Why?
|
| Mutation | 6 | 2011 | 30220 | 0.030 |
Why?
|
| Adrenalectomy | 1 | 2017 | 347 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2018 | 374 | 0.030 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2017 | 216 | 0.030 |
Why?
|
| Infant, Premature | 2 | 2017 | 2121 | 0.030 |
Why?
|
| Angiotensin II Type 2 Receptor Blockers | 1 | 2014 | 8 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 712 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2018 | 4348 | 0.030 |
Why?
|
| Protein Transport | 2 | 2013 | 1940 | 0.030 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2014 | 61 | 0.030 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1994 | 74 | 0.030 |
Why?
|
| Iliac Artery | 1 | 1996 | 344 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3788 | 0.030 |
Why?
|
| Symbiosis | 1 | 2017 | 297 | 0.030 |
Why?
|
| Constriction | 1 | 1994 | 167 | 0.030 |
Why?
|
| Integrin beta Chains | 1 | 1995 | 116 | 0.030 |
Why?
|
| Obesity | 1 | 2017 | 13088 | 0.030 |
Why?
|
| Denervation | 1 | 2015 | 265 | 0.030 |
Why?
|
| Rheology | 1 | 1995 | 347 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2017 | 409 | 0.030 |
Why?
|
| Glycocalyx | 1 | 2015 | 98 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 153 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2018 | 1441 | 0.030 |
Why?
|
| Polyesters | 1 | 2016 | 373 | 0.030 |
Why?
|
| Renal Circulation | 1 | 2014 | 288 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2001 | 1801 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 13410 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2014 | 6212 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 214 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 380 | 0.030 |
Why?
|
| von Willebrand Factor | 2 | 2011 | 680 | 0.030 |
Why?
|
| Nanocapsules | 1 | 2014 | 92 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2001 | 2201 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 1587 | 0.030 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1994 | 282 | 0.030 |
Why?
|
| Hemolysin Proteins | 1 | 2013 | 113 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 946 | 0.030 |
Why?
|
| Dermis | 2 | 2006 | 203 | 0.030 |
Why?
|
| Aorta | 2 | 2014 | 2041 | 0.030 |
Why?
|
| Polyglycolic Acid | 1 | 2014 | 406 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 3721 | 0.030 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2014 | 98 | 0.030 |
Why?
|
| Dogs | 1 | 2018 | 3834 | 0.030 |
Why?
|
| Monte Carlo Method | 2 | 2009 | 1249 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 1749 | 0.030 |
Why?
|
| Hematocrit | 1 | 1994 | 622 | 0.030 |
Why?
|
| Triglycerides | 1 | 2021 | 2441 | 0.030 |
Why?
|
| Microspheres | 1 | 2016 | 774 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2024 | 1542 | 0.030 |
Why?
|
| Platelet Aggregation | 2 | 2008 | 769 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5753 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 1993 | 411 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2014 | 289 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2017 | 614 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2013 | 439 | 0.030 |
Why?
|
| Acute Disease | 1 | 2003 | 7240 | 0.030 |
Why?
|
| Cell Surface Extensions | 1 | 2012 | 65 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2014 | 169 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 194 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 800 | 0.030 |
Why?
|
| Gangliosides | 1 | 1993 | 132 | 0.030 |
Why?
|
| Factor VIII | 1 | 2014 | 348 | 0.030 |
Why?
|
| Retroviridae | 2 | 2006 | 845 | 0.030 |
Why?
|
| Organoids | 1 | 2018 | 741 | 0.020 |
Why?
|
| Kidney | 1 | 2007 | 7071 | 0.020 |
Why?
|
| Giant Cells | 1 | 2012 | 187 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 1998 | 1408 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2014 | 8300 | 0.020 |
Why?
|
| Galactosylceramides | 1 | 2012 | 90 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2002 | 2559 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 5794 | 0.020 |
Why?
|
| HMGB Proteins | 1 | 2011 | 45 | 0.020 |
Why?
|
| Neutrophil Activation | 1 | 2012 | 180 | 0.020 |
Why?
|
| Hemophilia A | 1 | 2014 | 358 | 0.020 |
Why?
|
| Clodronic Acid | 1 | 2011 | 60 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2012 | 311 | 0.020 |
Why?
|
| Antigens, CD1d | 1 | 2012 | 226 | 0.020 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2011 | 105 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4521 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1245 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 2012 | 433 | 0.020 |
Why?
|
| Receptors, Scavenger | 1 | 2011 | 123 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2014 | 498 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2003 | 1918 | 0.020 |
Why?
|
| Blood Preservation | 1 | 2011 | 169 | 0.020 |
Why?
|
| Cricetinae | 4 | 1997 | 2416 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 684 | 0.020 |
Why?
|
| AT Rich Sequence | 1 | 2010 | 10 | 0.020 |
Why?
|
| Virulence | 1 | 2014 | 1294 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2011 | 145 | 0.020 |
Why?
|
| Oxygen | 1 | 2002 | 4251 | 0.020 |
Why?
|
| Gene Targeting | 2 | 2006 | 840 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2012 | 562 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2011 | 3585 | 0.020 |
Why?
|
| Blood Cell Count | 2 | 2004 | 405 | 0.020 |
Why?
|
| Blood Donors | 1 | 2012 | 344 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 2012 | 540 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1991 | 446 | 0.020 |
Why?
|
| Capillary Permeability | 2 | 2004 | 770 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2014 | 1137 | 0.020 |
Why?
|
| Mesocricetus | 3 | 1995 | 256 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2011 | 1168 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2018 | 2869 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10740 | 0.020 |
Why?
|
| Thioglycolates | 2 | 2000 | 37 | 0.020 |
Why?
|
| AIDS Vaccines | 1 | 2015 | 898 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 2675 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 1208 | 0.020 |
Why?
|
| Chemokine CXCL13 | 1 | 2009 | 62 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1995 | 943 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 1476 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2011 | 480 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2015 | 2341 | 0.020 |
Why?
|
| Glutamates | 1 | 1990 | 384 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 615 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1602 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2013 | 541 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 1494 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2013 | 922 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 1963 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 1837 | 0.020 |
Why?
|
| Imidazoles | 1 | 2014 | 1168 | 0.020 |
Why?
|
| Temperature | 1 | 2014 | 2229 | 0.020 |
Why?
|
| Interferons | 1 | 2011 | 714 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2009 | 215 | 0.020 |
Why?
|
| Succinimides | 1 | 2007 | 83 | 0.020 |
Why?
|
| Endotoxins | 1 | 2010 | 519 | 0.020 |
Why?
|
| Perfusion | 1 | 1992 | 1409 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2003 | 3788 | 0.020 |
Why?
|
| Hepatitis B virus | 1 | 2011 | 531 | 0.020 |
Why?
|
| Adult | 5 | 2017 | 223253 | 0.020 |
Why?
|
| Virus Replication | 1 | 2015 | 2457 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2009 | 4141 | 0.020 |
Why?
|
| Liposomes | 1 | 2011 | 787 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2011 | 652 | 0.020 |
Why?
|
| Homeodomain Proteins | 2 | 2007 | 2430 | 0.020 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2009 | 305 | 0.020 |
Why?
|
| Caspases, Initiator | 1 | 2007 | 31 | 0.020 |
Why?
|
| Breeding | 1 | 2006 | 49 | 0.020 |
Why?
|
| Nanomedicine | 1 | 2010 | 289 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2844 | 0.020 |
Why?
|
| Sepsis | 2 | 2001 | 2604 | 0.020 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2009 | 179 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 3803 | 0.020 |
Why?
|
| Biophysics | 1 | 2008 | 375 | 0.020 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2007 | 42 | 0.020 |
Why?
|
| Syndrome | 1 | 1993 | 3271 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2007 | 185 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2168 | 0.020 |
Why?
|
| Orthomyxoviridae | 1 | 2007 | 148 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2825 | 0.020 |
Why?
|
| Endopeptidases | 2 | 2003 | 762 | 0.020 |
Why?
|
| Bacteria | 1 | 2017 | 2212 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 20129 | 0.020 |
Why?
|
| Gadolinium | 1 | 2011 | 963 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2007 | 456 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 372 | 0.020 |
Why?
|
| Immunoglobulin D | 1 | 2005 | 55 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 1429 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 3608 | 0.020 |
Why?
|
| Receptors, Complement 3d | 1 | 2005 | 117 | 0.020 |
Why?
|
| Brain Edema | 1 | 1990 | 601 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2455 | 0.020 |
Why?
|
| Talin | 1 | 2005 | 47 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 2135 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 5021 | 0.020 |
Why?
|
| Thymoma | 1 | 2006 | 186 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2006 | 303 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6507 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2009 | 6259 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2007 | 575 | 0.020 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2004 | 22 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 928 | 0.010 |
Why?
|
| Premature Birth | 1 | 2017 | 1830 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2010 | 1206 | 0.010 |
Why?
|
| Connective Tissue | 1 | 2007 | 425 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2004 | 216 | 0.010 |
Why?
|
| Cattle | 1 | 2010 | 3814 | 0.010 |
Why?
|
| Lectins | 1 | 2006 | 490 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2005 | 163 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 1729 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 2004 | 176 | 0.010 |
Why?
|
| Acetylglucosamine | 1 | 2005 | 188 | 0.010 |
Why?
|
| Plasma Cells | 1 | 2007 | 599 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2059 | 0.010 |
Why?
|
| Bone Density Conservation Agents | 1 | 2011 | 791 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 1999 | 4561 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9401 | 0.010 |
Why?
|
| Cytidine Deaminase | 1 | 2005 | 249 | 0.010 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2004 | 116 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2018 | 6422 | 0.010 |
Why?
|
| Germ Cells | 1 | 2007 | 646 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2007 | 1228 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2004 | 421 | 0.010 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 2003 | 13 | 0.010 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2004 | 147 | 0.010 |
Why?
|
| Solubility | 1 | 2005 | 1078 | 0.010 |
Why?
|
| Communicable Disease Control | 1 | 2010 | 857 | 0.010 |
Why?
|
| T-Box Domain Proteins | 1 | 2006 | 471 | 0.010 |
Why?
|
| Amoeba | 1 | 2003 | 20 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 2004 | 230 | 0.010 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2003 | 59 | 0.010 |
Why?
|
| Receptors, CCR3 | 1 | 2002 | 62 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 1995 | 939 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1525 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2004 | 540 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2446 | 0.010 |
Why?
|
| Cell Count | 1 | 2006 | 1826 | 0.010 |
Why?
|
| Drug Design | 1 | 2007 | 1042 | 0.010 |
Why?
|
| Tissue Transplantation | 1 | 2003 | 128 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2007 | 749 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 332 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 1884 | 0.010 |
Why?
|
| Epithelium | 1 | 2006 | 1606 | 0.010 |
Why?
|
| Listeriosis | 1 | 2003 | 146 | 0.010 |
Why?
|
| Thrombin | 1 | 2004 | 600 | 0.010 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2001 | 48 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 1729 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1657 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2010 | 2495 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2006 | 2127 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2017 | 8061 | 0.010 |
Why?
|
| Morpholines | 1 | 2004 | 584 | 0.010 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2001 | 72 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 2003 | 245 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9352 | 0.010 |
Why?
|
| Cell Size | 1 | 2003 | 626 | 0.010 |
Why?
|
| Transgenes | 1 | 2004 | 1014 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2006 | 1075 | 0.010 |
Why?
|
| Ligation | 1 | 2001 | 446 | 0.010 |
Why?
|
| Palatine Tonsil | 1 | 2001 | 193 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2005 | 1527 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 898 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 624 | 0.010 |
Why?
|
| Antigens, CD19 | 1 | 2003 | 443 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2002 | 755 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2003 | 1085 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2005 | 1179 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 2003 | 610 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2009 | 2141 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2004 | 712 | 0.010 |
Why?
|
| Ferric Compounds | 1 | 2001 | 376 | 0.010 |
Why?
|
| K562 Cells | 1 | 2001 | 645 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 13472 | 0.010 |
Why?
|
| Indoles | 1 | 2007 | 1832 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2006 | 1404 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3795 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 750 | 0.010 |
Why?
|
| Cesium Radioisotopes | 1 | 1998 | 38 | 0.010 |
Why?
|
| Aged | 3 | 2017 | 171234 | 0.010 |
Why?
|
| Immunomagnetic Separation | 1 | 1999 | 78 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2007 | 2925 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3481 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1994 | 8532 | 0.010 |
Why?
|
| Hemorheology | 1 | 1999 | 144 | 0.010 |
Why?
|
| Fibrin | 1 | 2001 | 514 | 0.010 |
Why?
|
| Chlorides | 1 | 2001 | 666 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 3681 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 1998 | 351 | 0.010 |
Why?
|
| Ear, External | 1 | 1999 | 165 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2004 | 1144 | 0.010 |
Why?
|
| Rats | 2 | 2011 | 23718 | 0.010 |
Why?
|
| Brain Injuries | 1 | 1990 | 2053 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4047 | 0.010 |
Why?
|
| Edema | 1 | 2002 | 764 | 0.010 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1997 | 58 | 0.010 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1997 | 64 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1998 | 752 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 1363 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 2880 | 0.010 |
Why?
|
| Middle Aged | 3 | 2017 | 223127 | 0.010 |
Why?
|
| Thromboxane A2 | 1 | 1997 | 87 | 0.010 |
Why?
|
| Splenectomy | 1 | 1998 | 390 | 0.010 |
Why?
|
| Calcimycin | 1 | 1997 | 214 | 0.010 |
Why?
|
| Opsonin Proteins | 1 | 1996 | 144 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 1996 | 110 | 0.010 |
Why?
|
| Naphthalenes | 1 | 1997 | 198 | 0.010 |
Why?
|
| Differential Threshold | 1 | 1996 | 80 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 1767 | 0.010 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1996 | 175 | 0.010 |
Why?
|
| Muscles | 1 | 2000 | 1576 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2007 | 3460 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2001 | 1162 | 0.010 |
Why?
|
| 1-Butanol | 1 | 1995 | 13 | 0.010 |
Why?
|
| Butanols | 1 | 1995 | 19 | 0.010 |
Why?
|
| Leukocytosis | 1 | 1996 | 249 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1995 | 53 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 1995 | 142 | 0.010 |
Why?
|
| Child | 1 | 2003 | 80668 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 484 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5696 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 1995 | 139 | 0.010 |
Why?
|
| CHO Cells | 1 | 1997 | 1376 | 0.010 |
Why?
|
| Videotape Recording | 1 | 1996 | 333 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7607 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 3400 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 689 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 2715 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 1677 | 0.010 |
Why?
|
| Heart | 1 | 2006 | 4421 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4618 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 3439 | 0.010 |
Why?
|
| Cheek | 1 | 1991 | 66 | 0.010 |
Why?
|
| Mitochondria | 1 | 2003 | 3676 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1999 | 2839 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1992 | 42576 | 0.010 |
Why?
|
| Permeability | 1 | 1991 | 728 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 1991 | 434 | 0.000 |
Why?
|
| Survival Analysis | 1 | 2001 | 10092 | 0.000 |
Why?
|
| Body Water | 1 | 1990 | 337 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2078 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1991 | 675 | 0.000 |
Why?
|
| Algorithms | 1 | 2008 | 14071 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1990 | 951 | 0.000 |
Why?
|
| Survivors | 1 | 1997 | 2379 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 2227 | 0.000 |
Why?
|
| Organ Size | 1 | 1990 | 2261 | 0.000 |
Why?
|
| Sodium | 1 | 1990 | 1593 | 0.000 |
Why?
|
| Glutamic Acid | 1 | 1990 | 1181 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2006 | 41703 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1999 | 8619 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 18075 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1997 | 15897 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1997 | 59538 | 0.000 |
Why?
|
| Brain | 1 | 1990 | 27156 | 0.000 |
Why?
|